Contract research company Pharmaceutical Product Development Inc. said late Wednesday it completed the buyout of Russian drug development services company InnoPharm Ltd.
Financial details of the deal were not disclosed.
In February, Pharmaceutical Product Development, or PPD, said it was buying the company in a move to expand its global reach. The deal adds offices in Russia and Ukraine. InnoPharm offers midstage to post-marketing clinical services and employs more than 300 people.
PPD provides drug discovery and development services to pharmaceutical, biotech and medical device companies.
Shares of PPD rose 13 cents to $40.01 in morning trading.
Financial details of the deal were not disclosed.
In February, Pharmaceutical Product Development, or PPD, said it was buying the company in a move to expand its global reach. The deal adds offices in Russia and Ukraine. InnoPharm offers midstage to post-marketing clinical services and employs more than 300 people.
PPD provides drug discovery and development services to pharmaceutical, biotech and medical device companies.
Shares of PPD rose 13 cents to $40.01 in morning trading.
0 comments:
Post a Comment